✦ LIBER ✦

Autoantibodies present in chronic hepatitis c and chronic hepatitis B viral infections

✍ Scribed by David L. Smalley; Mary F. Hall; Clifford L. Broughton

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 37 KB
Volume: 27
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510270542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delayed HBsAg clearance in chronic hepat

Delayed HBsAg clearance in chronic hepatitis B viral infection

✍ Karen L. Lindsay; Allan G. Redeker; Mary Ashcavai 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

Seven patients are described in whom HBsAg persisted for 13 to 98 months after acute viral hepatitis B and then became nondetectable. All patients subsequently developed anti-HBs. During the period of HBs-antigenemia, liver biopsies in five patients showed persistent viral hepatitis. Retrospectively

Hepatitis C viral quasispecies and liver

Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection

✍ J Hayashi; Y Kishihara; K Yamaji; N Furusyo; T Yamamoto; Y Pae; Y Etoh; H Ikemat 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

To clarify the virological differences in patients with chronic hepatitis C virus (HCV) infection with and without liver damage, we assessed HCV markers in 306 patients from a rural area of Japan. Genotypes of HCV RNA were determined by polymerase chain reaction, and levels of RNA were determined by

Iron and chronic viral hepatitis

✍ H L Bonkovsky; B F Banner; A L Rothman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

of an in vitro system for propagation of these viruses compliof Medicine, Worcester, MA. cates these efforts.

Autoantibody prevalence in chronic hepat

Autoantibody prevalence in chronic hepatitis B virus infection: Effect in interferon alfa

✍ G V Gregorio; H Jones; K Choudhuri; A Vegnente; F Bortolotti; G Mieli-Vergani; D 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

albeit with different prevalences, and a third report suggests The most effective treatment of chronic hepatitis B that IFN-a may be a trigger for autoimmune hepatitis. 13 To virus (HBV) infection is interferon alfa (IFN-a), a potenaddress the question as to whether any clinical or serological tiall

Decreased nitric oxide production in chr

Decreased nitric oxide production in chronic viral hepatitis B and C

✍ Amaro, María José; Bartolomé, Javier; Pardo, Margarita; Cotonat, Teresa; López-F 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

Nitric oxide is a free radical gas molecule which may be implicated in antiviral defense. However, there is no information about its possible role in chronic viral hepatitis B and C. In this study we have analyzed the serum levels of NO 2 -(as an index of nitric oxide generation) from patients with

Acyclovir in chronic hepatitis B virus i

Acyclovir in chronic hepatitis B virus infection

✍ Geoffrey M. Dusheiko 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati